Description
Laudatio. Conformational diseases: Misfolding mechanisms may pave the way to early therapy (C. Reiss et al.). Editorial. Tribute to Professor Toshiharu Nagatsu (M. Naoi et al.). Reviews. Amine-related neurotoxins in Parkinson’s disease: Past, present, and future (T. Nagatsu). Potential neurotoxic “agents provocateurs” in Parkinson’s disease (M.A. Collins et al.). Dopamine-derived endogenous N-methyl-(R)-salsolinol: Its role in Parkinson’s disease (M. Naoi et al.). N-methylation underlying Parkinson’s disease (K. Matsubara et al.). Apoptotic molecules and MPTP-induced cell death (A. Nicotra, S.H. Parvez). MPTO: Insights into parkinsonian neurodegeneration (S.G. Speciale). Influence of neuromelanin on oxidative pathways within the human substantia nigra (K.L. Double et al.). DOPA causes glutamate release and delayed neuron death by brain ischemia in rats (Y. Misu et al.). Manganese-induced apoptosis in PC12 cells (Y. Hirata). Physiological role of salsolinol: Its hypophysiotrophic function in the regulation of pituitary prolactin secretion (B.E. Tth et al.). Aliphatic propargylamines as symptomatic and neuroprotective treatments for neurodegenerative diseases (M.D. Berry, A.A. Boulton). Neuroprotection by propargylamines in Parkinson’s disease: Suppression of apoptosis and induction of prosurvival genes (W. Maruyama et al.). Docosahexaenoic acid attenuated hypertension and vascular dementia in stroke-prone spontaneously hypertensive rats (S. Kimura et al.). Diabetic neuropathies in brain are induced by deficiency of BDNF (A. Nitta et al.).
